Positive Results for CeQur SA's PaQ® Insulin Delivery Device
3/1/2013 6:57:45 AM
More...
|
CeQur SA Announces Positive Results From Study Evaluating Simple Insulin Delivery Device Among People With Type 2 Diabetes
2/28/2013 11:30:15 AM
More...
|
CeQur SA Appoints Michael Trautmann, MD Medical Director for Anti-Diabetic Peptides
12/11/2012 9:41:25 AM
More...
|
CeQur SA Receives CE Mark for PaQ® Insulin Delivery Device
11/27/2012 8:13:48 AM
More...
|
CeQur SA Completes Study Evaluating Ability of Simple Insulin Delivery Device to Replace Insulin Injections Among People With Type 2 Diabetes
9/26/2012 10:09:25 AM
More...
|
CeQur SA Initiates Clinical Study of Simple Insulin Delivery Device for People with Type 2 Diabetes
6/6/2012 11:41:23 AM
More...
|
CeQur SA Completes Series A Investment With 10 Million Dollars Raised in December 2009 Bringing Total to $29.6M
1/5/2010 10:23:48 AM
More...
|
CeQur SA Appoints Eric Milledge Chairman of the Board of Directors
10/6/2009 8:28:49 AM
More...
|